Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Gastroenterology

Is a breath test or endoscopy better for diagnosing CSID?

At a Glance

Neither test is universally better for diagnosing CSID. Endoscopy with a small-intestinal biopsy directly measures enzyme activity and can check for other diseases, while the 13C-sucrose breath test is less invasive but has uncertain accuracy and may not match biopsy results.

The short answer is that neither test is perfect on its own, and the “better” test depends heavily on your or your child’s specific symptoms. An upper endoscopy (often called an EGD) is a procedure used to collect tissue samples so a laboratory can directly measure enzyme activity [1][2]. It is widely considered a reference method, but it is an invasive procedure. The 13C-sucrose breath test offers a non-invasive alternative that measures exhaled gases, which is especially appealing for children. However, research shows breath test results do not always match the results of a tissue biopsy, and there is no universally validated accuracy rate for the breath test [3][4].

Clinicians weigh the risks of an invasive procedure against the need to investigate other digestive diseases when deciding which test to recommend [5].

Understanding the Terms

  • CSID (Congenital Sucrase-Isomaltase Deficiency): A rare genetic disorder where the body lacks the enzymes sucrase (which digests table sugar) and isomaltase (which digests maltose and starches).
  • EGD (Esophagogastroduodenoscopy): A procedure where a doctor looks at the upper digestive tract using a small camera.
  • 13C: A safe, non-radioactive carbon label used in breath testing to track how a substance is broken down.
  • Disaccharidase Assay: A laboratory test performed on a tissue biopsy to measure how well enzymes like sucrase are working.

The Reference Method: Endoscopy and Biopsy

During an EGD, a doctor passes a small tube down the throat to take tiny tissue samples (biopsies) from the small intestine. A laboratory then performs a disaccharidase assay on the tissue [1][6].

Pros of the Biopsy Approach:

  • Direct Measurement: The assay directly measures the enzyme activity in the intestinal lining [1].
  • Helps Evaluate Other Conditions: An EGD allows the doctor to check for other issues that cause similar symptoms, such as celiac disease or certain upper gastrointestinal inflammation [7].

Important Celiac Disease Precaution: If you are being evaluated for celiac disease alongside CSID, do not start a gluten-free diet before testing unless advised by your doctor. Removing gluten can heal the gut, making celiac blood tests and biopsies falsely reassuring (a false negative) [7][8].

Cons of the Biopsy Approach:

  • Invasive: It requires sedation or general anesthesia—the exact type varies by age and medical center—which carries risks and logistics [3][9].
  • Acquired vs. Congenital: A biopsy can show low enzyme levels, but it cannot always tell you why. Enzyme levels can drop temporarily due to gut damage from untreated celiac disease or infections. This is known as acquired sucrase-isomaltase deficiency, which can look identical to congenital (lifelong) CSID on a biopsy [1][7][4].
  • Patchy Results and Handling: Enzyme activity is not always distributed evenly throughout the small intestine, meaning a biopsy might sample a spot with normal activity and miss the deficiency [3][10]. The accuracy also heavily depends on the samples being quickly and properly transported to the lab [4].

The 13C-Sucrose Breath Test: An Indirect, Non-Invasive Alternative

The breath test involves drinking a solution containing a harmless form of sugar (13C-sucrose). If your body digests it properly, the sugar breaks down and is exhaled as carbon dioxide. You blow into a collection tube at set intervals to measure the exhaled 13CO2.

Pros of the Breath Test:

  • Non-Invasive: There is no tube passed down the throat, and no sedation or anesthesia is required [5]. Depending on the laboratory, it can sometimes be done at home or in a clinic [11].
  • No Procedural Risks: It avoids the medical risks associated with an endoscopy.

Cons of the Breath Test:

  • Accuracy and Discordant Results: Medical literature highlights that the breath test requires further validation and does not have a universally accepted sensitivity (true positive) or specificity (true negative) rate [1]. Small studies have shown mismatches between breath test results and biopsies. For example, in one study of 40 adults, breath test curves did not correlate with biopsy sucrase activity [3]. In a highly specific pediatric study of 21 children who already had low sucrase levels on a biopsy, only 33% (7 children) had an abnormal breath test result [4]. These figures are not universal accuracy rates, but they illustrate that the test is not foolproof.
  • Outside Factors: Because the breath test is an indirect measure, the results can be altered by factors unrelated to CSID, such as gastric emptying (how fast your stomach empties), your body weight, or Small Intestinal Bacterial Overgrowth (SIBO) [12][13].

How Clinicians Decide

Choosing between these tests can be stressful, particularly when the patient is a child. A clinician does not simply look at one test, but combines the results with growth charts, symptom history, and other labs.

  • Considerations for Non-Invasive Testing: If a child or adult has classic symptoms of sucrose intolerance but no other alarming signs, a doctor may suggest starting with the non-invasive breath test [5].
  • When an Endoscopy is Helpful: If a patient has severe symptoms, persistent vomiting, bleeding, unexplained weight loss, poor growth (“failure to thrive”), or blood tests indicating possible celiac disease, a broader evaluation is typically needed. An EGD helps ensure doctors do not miss other serious, treatable conditions [7][5].

The Role of Genetic Testing
Clinicians sometimes use genetic testing to help clarify confusing results from breath tests and biopsies [14]. However, genetic testing is not definitive on its own. A negative genetic panel does not rule out acquired sucrase deficiency, and finding a genetic variant (especially one of “uncertain significance”) does not automatically prove it is the cause of your symptoms [14].

Preparing for Your Test

Regardless of which test you and your doctor choose, preparation is key:

  • Ask for Instructions: Breath test results can be affected by fasting times, recent antibiotics, probiotics, diet, smoking, and physical activity. Check which specific test is being ordered and what the preparation timeline is.
  • Do Not Stop Medications on Your Own: Always ask your testing center what medications or supplements must be paused, but do not stop taking prescribed treatments without consulting your clinician first.

Common questions in this guide

Is a CSID breath test more accurate than an endoscopy?
Neither test is universally better. Endoscopy with a small-intestinal biopsy directly measures sucrase and other enzyme activity and can look for conditions such as celiac disease, but it is invasive. The 13C-sucrose breath test avoids sedation and procedures, yet its accuracy is not universally established and results may disagree with biopsy findings.
Why might my doctor recommend an endoscopy when CSID is suspected?
An endoscopy may be useful when symptoms are severe or persistent, or when there is vomiting, bleeding, unexplained weight loss, poor growth, or concern about celiac disease. It allows the clinician to examine the upper digestive tract and obtain tissue for enzyme testing while evaluating other conditions.
Can celiac testing be affected by starting a gluten-free diet?
Yes. Removing gluten before celiac blood tests or biopsies can allow the intestine to heal and make results falsely reassuring. Do not start a gluten-free diet for this evaluation unless your clinician advises you to do so.
What does a normal CSID breath test mean if symptoms continue?
A normal breath test does not by itself explain ongoing symptoms or completely exclude a sucrase problem, because breath results can disagree with biopsy findings. Ask your clinician whether other causes, test preparation, celiac disease, or an endoscopy or other evaluation should be considered.
Can genetic testing confirm or rule out CSID?
Genetic testing can sometimes help interpret unclear breath-test or biopsy results, but it is not definitive by itself. A negative panel does not rule out acquired sucrase deficiency, and a variant of uncertain significance does not prove that it causes symptoms.
How should I prepare for a 13C-sucrose breath test?
Follow the testing center's instructions about fasting, diet, antibiotics, probiotics, smoking, activity, and medicines because these factors can affect results. Do not stop prescribed medicines or supplements on your own; ask the testing center or clinician what should be paused.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my (or my child's) specific symptoms, is an endoscopy necessary to evaluate for other conditions, or is a breath test an appropriate starting point?
  2. 2.If the breath test comes back normal but symptoms continue, what would our next step be?
  3. 3.If we proceed with a biopsy, does your facility have experience properly handling and transporting samples for a disaccharidase assay?
  4. 4.Would you recommend a genetic test for CSID, and what are its limitations in our case?
  5. 5.How do you handle a situation where a patient has classic CSID symptoms, but the breath test or biopsy comes back normal?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Genetic and acquired sucrase-isomaltase deficiency: A clinical review.

    Danialifar TF, Chumpitazi BP, Mehta DI, Di Lorenzo C

    Journal of pediatric gastroenterology and nutrition 2024; (78(4)):774-782 doi:10.1002/jpn3.12151.

    PMID: 38327254
  2. 2

    Congenital sucrase-isomaltase deficiency: diagnostic challenges and response to enzyme replacement therapy.

    Puntis JW, Zamvar V

    Archives of disease in childhood 2015; (100(9)):869-71 doi:10.1136/archdischild-2015-308388.

    PMID: 26163121
  3. 3

    Diagnosing sucrase-isomaltase deficiency: a comparison of a 13C-sucrose breath test and a duodenal enzyme assay.

    Dale HF, Hagen M, Deb C, et al.

    Scandinavian journal of clinical and laboratory investigation 2024; (84(4)):268-272 doi:10.1080/00365513.2024.2377960.

    PMID: 38984772
  4. 4

    Diagnosing Congenital Sucrase-Isomaltase Deficiency in Children: An Algorithm Using Combined Breath Testing.

    Hoskins BJ, Freeman J, Kutty S, et al.

    Pediatric gastroenterology, hepatology & nutrition 2026; (29(2)):120-130 doi:10.5223/pghn.2026.29.2.120.

    PMID: 41877710
  5. 5

    Demystifying Carbohydrate Maldigestion: A Clinical Review.

    Cash BD, Patel D, Scarlata K

    The American journal of gastroenterology 2025; (120(4S)):1-11 doi:10.14309/ajg.0000000000003374.

    PMID: 40249016
  6. 6

    Sucrose intolerance in adults with common functional gastrointestinal symptoms.

    Frissora CL, Rao SSC

    Proceedings (Baylor University. Medical Center) 2022; (35(6)):790-793 doi:10.1080/08998280.2022.2114070.

    PMID: 36304608
  7. 7

    Clinical and Histopathologic Predictors of Disaccharidase Deficiency in Duodenal Biopsy Specimens.

    Reed RC, Pacheco MC

    American journal of clinical pathology 2019; (152(6)):742-746 doi:10.1093/ajcp/aqz091.

    PMID: 31332425
  8. 8

    Disaccharidase activity in children undergoing esophagogastroduodenoscopy: A systematic review.

    Daileda T, Baek P, Sutter ME, Thakkar K

    World journal of gastrointestinal pharmacology and therapeutics 2016; (7(2)):283-93 doi:10.4292/wjgpt.v7.i2.283.

    PMID: 27158545
  9. 9

    NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders.

    Esposito MV, Comegna M, Cernera G, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020262.

    PMID: 33567694
  10. 10

    Disaccharidase deficiencies and gastrointestinal symptoms in patients referred to gastroscopic examination: a single center study from Norway.

    Dale HF, Hagen M, Bekkelund M, et al.

    Scandinavian journal of gastroenterology 2024; (59(10)):1166-1171 doi:10.1080/00365521.2024.2395848.

    PMID: 39230142
  11. 11

    Sucrase Breath Testing in Children Presenting With Chronic Abdominal Pain.

    Rathod S, Friesen CA, Radford K, Colombo JM

    Clinical pediatrics 2020; (59(13)):1191-1194 doi:10.1177/0009922820942183.

    PMID: 32686473
  12. 12

    A Model-Based 13C-Sucrose Breath Test Diagnostic for Gut Function Disorders Characterized by a Loss of Sucrase-Isomaltase Enzymatic Activity.

    Brouwer AF, Lee GO, Van Wyk H, et al.

    The Journal of nutrition 2024; (154(3)):815-825 doi:10.1016/j.tjnut.2023.11.017.

    PMID: 37995914
  13. 13

    Associations of 13C-Sucrose Breath Test Dynamics with Anthropometry and Demographics: A Comparison of Studies in the United Kingdom and Zambia.

    Iorga SP, Van Wyk H, Lee GO, et al.

    Current developments in nutrition 2025; (9(11)):107590 doi:10.1016/j.cdnut.2025.107590.

    PMID: 41334051
  14. 14

    Sucrase-isomaltase Gene Variants in Patients With Abnormal Sucrase Activity and Functional Gastrointestinal Disorders.

    Deb C, Campion S, Derrick V, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (72(1)):29-35 doi:10.1097/MPG.0000000000002852.

    PMID: 32732636

This comparison of CSID breath testing and endoscopy is for informational purposes only and does not constitute medical advice. Your gastroenterology team can recommend the safest next step for you or your child based on symptoms, test goals, and medical history.

Get notified when new evidence is published on Congenital sucrase-isomaltase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.